-
1
-
-
84890180201
-
Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells
-
Jensen MC, Riddell SR,. Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells. Immunol Rev 2014; 257: 127-44.
-
(2014)
Immunol Rev
, vol.257
, pp. 127-144
-
-
Jensen, M.C.1
Riddell, S.R.2
-
2
-
-
84890321001
-
TCR-engineered T cells meet new challenges to treat solid tumors: Choice of antigen, T cell fitness, and sensitization of tumor milieu
-
Kunert A, Straetemans T, Govers C, et al. TCR-engineered T cells meet new challenges to treat solid tumors: choice of antigen, T cell fitness, and sensitization of tumor milieu. Front Immunol 2013; 4: 363.
-
(2013)
Front Immunol
, vol.4
, pp. 363
-
-
Kunert, A.1
Straetemans, T.2
Govers, C.3
-
3
-
-
84858758766
-
Adoptive immunotherapy for cancer: Harnessing the T cell response
-
Restifo NP, Dudley ME, Rosenberg SA,. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 2012; 12: 269-81.
-
(2012)
Nat Rev Immunol
, vol.12
, pp. 269-281
-
-
Restifo, N.P.1
Dudley, M.E.2
Rosenberg, S.A.3
-
4
-
-
84859153479
-
Raising the bar: The curative potential of human cancer immunotherapy
-
Rosenberg SA,. Raising the bar: the curative potential of human cancer immunotherapy. Sci Transl Med 2012; 4: 127ps8.
-
(2012)
Sci Transl Med
, vol.4
, pp. 127ps8
-
-
Rosenberg, S.A.1
-
5
-
-
16444381331
-
Bcl-2 overexpression enhances tumor-specific T-cell survival
-
Charo J, Finkelstein SE, Grewal N, et al. Bcl-2 overexpression enhances tumor-specific T-cell survival. Cancer Res 2005; 65: 2001-8.
-
(2005)
Cancer Res
, vol.65
, pp. 2001-2008
-
-
Charo, J.1
Finkelstein, S.E.2
Grewal, N.3
-
6
-
-
33749624177
-
Cancer regression in patients after transfer of genetically engineered lymphocytes
-
Morgan RA, Dudley ME, Wunderlich JR, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006; 314: 126-9.
-
(2006)
Science
, vol.314
, pp. 126-129
-
-
Morgan, R.A.1
Dudley, M.E.2
Wunderlich, J.R.3
-
7
-
-
32944470811
-
Solid tumors "melt" from the inside after successful CD8 T cell attack
-
Blohm U, Potthoff D, van der Kogel AJ, et al. Solid tumors "melt" from the inside after successful CD8 T cell attack. Eur J Immunol 2006; 36: 468-77.
-
(2006)
Eur J Immunol
, vol.36
, pp. 468-477
-
-
Blohm, U.1
Potthoff, D.2
Van Der Kogel, A.J.3
-
8
-
-
67650638846
-
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
-
Di Stasi A, De Angelis B, Rooney CM, et al. T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model. Blood 2009; 113: 6392-402.
-
(2009)
Blood
, vol.113
, pp. 6392-6402
-
-
Di Stasi, A.1
De Angelis, B.2
Rooney, C.M.3
-
9
-
-
0036428790
-
Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2
-
Kershaw MH, Wang G, Westwood JA, et al. Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2. Hum Gene Ther 2002; 13: 1971-80.
-
(2002)
Hum Gene Ther
, vol.13
, pp. 1971-1980
-
-
Kershaw, M.H.1
Wang, G.2
Westwood, J.A.3
-
10
-
-
77958063691
-
Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b
-
Craddock JA, Lu A, Bear A, et al. Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b. J Immunother 2010; 33: 780-8.
-
(2010)
J Immunother
, vol.33
, pp. 780-788
-
-
Craddock, J.A.1
Lu, A.2
Bear, A.3
-
11
-
-
13644251904
-
Advances in imaging mouse tumour models in vivo
-
Lyons SK,. Advances in imaging mouse tumour models in vivo. J Pathol 2005; 205: 194-205.
-
(2005)
J Pathol
, vol.205
, pp. 194-205
-
-
Lyons, S.K.1
-
13
-
-
75749126550
-
Bioluminescent imaging: A critical tool in pre-clinical oncology research
-
O'Neill K, Lyons SK, Gallagher WM, et al. Bioluminescent imaging: a critical tool in pre-clinical oncology research. J Pathol 2010; 220: 317-27.
-
(2010)
J Pathol
, vol.220
, pp. 317-327
-
-
O'Neill, K.1
Lyons, S.K.2
Gallagher, W.M.3
-
14
-
-
29144442848
-
Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo
-
Zhao H, Doyle TC, Coquoz O, et al. Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J Biomed Opt 2005; 10: 41210.
-
(2005)
J Biomed Opt
, vol.10
, pp. 41210
-
-
Zhao, H.1
Doyle, T.C.2
Coquoz, O.3
-
15
-
-
33644761970
-
Spectral unmixing of multicolored bioluminescence emitted from heterogeneous biological sources
-
Gammon ST, Leevy WM, Gross S, et al. Spectral unmixing of multicolored bioluminescence emitted from heterogeneous biological sources. Anal Chem 2006; 78: 1520-7.
-
(2006)
Anal Chem
, vol.78
, pp. 1520-1527
-
-
Gammon, S.T.1
Leevy, W.M.2
Gross, S.3
-
16
-
-
0036839884
-
Advancing animal models of neoplasia through in vivo bioluminescence imaging
-
Edinger M, Cao YA, Hornig YS, et al. Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 2002; 38: 2128-36.
-
(2002)
Eur J Cancer
, vol.38
, pp. 2128-2136
-
-
Edinger, M.1
Cao, Y.A.2
Hornig, Y.S.3
-
17
-
-
80054950816
-
Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors
-
Charo J, Perez C, Buschow C, et al. Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors. Eur J Immunol 2011; 41: 3187-97.
-
(2011)
Eur J Immunol
, vol.41
, pp. 3187-3197
-
-
Charo, J.1
Perez, C.2
Buschow, C.3
-
18
-
-
0037086089
-
Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice
-
Vooijs M, Jonkers J, Lyons S, et al. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res 2002; 62: 1862-7.
-
(2002)
Cancer Res
, vol.62
, pp. 1862-1867
-
-
Vooijs, M.1
Jonkers, J.2
Lyons, S.3
-
19
-
-
77951927091
-
In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance
-
Buschow C, Charo J, Anders K, et al. In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance. J Immunol 2010; 184: 2930-8.
-
(2010)
J Immunol
, vol.184
, pp. 2930-2938
-
-
Buschow, C.1
Charo, J.2
Anders, K.3
-
20
-
-
34547632147
-
Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence
-
Liao CP, Zhong C, Saribekyan G, et al. Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. Cancer Res 2007; 67: 7525-33.
-
(2007)
Cancer Res
, vol.67
, pp. 7525-7533
-
-
Liao, C.P.1
Zhong, C.2
Saribekyan, G.3
-
21
-
-
0242610921
-
The generation of a conditional reporter that enables bioluminescence imaging of cre/loxP-dependent tumorigenesis in mice
-
Lyons SK, Meuwissen R, Krimpenfort P, et al. The generation of a conditional reporter that enables bioluminescence imaging of cre/loxP-dependent tumorigenesis in mice. Cancer Res 2003; 63: 7042-6.
-
(2003)
Cancer Res
, vol.63
, pp. 7042-7046
-
-
Lyons, S.K.1
Meuwissen, R.2
Krimpenfort, P.3
-
22
-
-
0037438371
-
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging
-
Edinger M, Cao YA, Verneris MR, et al. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 2003; 101: 640-8.
-
(2003)
Blood
, vol.101
, pp. 640-648
-
-
Edinger, M.1
Cao, Y.A.2
Verneris, M.R.3
-
23
-
-
34247847666
-
T cells as a self-referential, sensory organ
-
Davis MM, Krogsgaard M, Huse M, et al. T cells as a self-referential, sensory organ. Annu Rev Immunol 2007; 25: 681-95.
-
(2007)
Annu Rev Immunol
, vol.25
, pp. 681-695
-
-
Davis, M.M.1
Krogsgaard, M.2
Huse, M.3
-
24
-
-
0037418009
-
Quantitative imaging of the T cell antitumor response by positron-emission tomography
-
Dubey P, Su H, Adonai N, et al. Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci USA 2003; 100: 1232-7.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 1232-1237
-
-
Dubey, P.1
Su, H.2
Adonai, N.3
-
25
-
-
34547521360
-
Monitoring the trafficking of adoptively transferred antigen- specific CD8-positive T cells in vivo, using noninvasive luminescence imaging
-
Kim D, Hung CF, Wu TC,. Monitoring the trafficking of adoptively transferred antigen- specific CD8-positive T cells in vivo, using noninvasive luminescence imaging. Hum Gene Ther 2007; 18: 575-88.
-
(2007)
Hum Gene Ther
, vol.18
, pp. 575-588
-
-
Kim, D.1
Hung, C.F.2
Wu, T.C.3
-
26
-
-
0142188700
-
In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors
-
Kircher MF, Allport JR, Graves EE, et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 2003; 63: 6838-46.
-
(2003)
Cancer Res
, vol.63
, pp. 6838-6846
-
-
Kircher, M.F.1
Allport, J.R.2
Graves, E.E.3
-
27
-
-
33646058046
-
Monitoring the antitumor response of naive and memory CD8 T cells in RAG1-/- mice by positron-emission tomography
-
Su H, Chang DS, Gambhir SS, et al. Monitoring the antitumor response of naive and memory CD8 T cells in RAG1-/- mice by positron-emission tomography. J Immunol 2006; 176: 4459-67.
-
(2006)
J Immunol
, vol.176
, pp. 4459-4467
-
-
Su, H.1
Chang, D.S.2
Gambhir, S.S.3
-
28
-
-
2942729789
-
Antigen distribution drives programmed antitumor CD8 cell migration and determines its efficiency
-
Boissonnas A, Combadiere C, Lavergne E, et al. Antigen distribution drives programmed antitumor CD8 cell migration and determines its efficiency. J Immunol 2004; 173: 222-9.
-
(2004)
J Immunol
, vol.173
, pp. 222-229
-
-
Boissonnas, A.1
Combadiere, C.2
Lavergne, E.3
-
29
-
-
33744534978
-
Cancer immunotherapy and preclinical studies: Why we are not wasting our time with animal experiments
-
Schreiber K, Rowley DA, Riethmuller G, et al. Cancer immunotherapy and preclinical studies: why we are not wasting our time with animal experiments. Hematol Oncol Clin North Am 2006; 20: 567-84.
-
(2006)
Hematol Oncol Clin North Am
, vol.20
, pp. 567-584
-
-
Schreiber, K.1
Rowley, D.A.2
Riethmuller, G.3
-
30
-
-
46949109577
-
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness
-
Willimsky G, Czeh M, Loddenkemper C, et al. Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness. J Exp Med 2008; 205: 1687-700.
-
(2008)
J Exp Med
, vol.205
, pp. 1687-1700
-
-
Willimsky, G.1
Czeh, M.2
Loddenkemper, C.3
-
31
-
-
24344436369
-
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance
-
Willimsky G, Blankenstein T,. Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 2005; 437: 141-6.
-
(2005)
Nature
, vol.437
, pp. 141-146
-
-
Willimsky, G.1
Blankenstein, T.2
-
32
-
-
78650311207
-
The immune response to sporadic colorectal cancer in a novel mouse model
-
Czeh M, Loddenkemper C, Shalapour S, et al. The immune response to sporadic colorectal cancer in a novel mouse model. Oncogene 2010; 29: 6591-602.
-
(2010)
Oncogene
, vol.29
, pp. 6591-6602
-
-
Czeh, M.1
Loddenkemper, C.2
Shalapour, S.3
-
33
-
-
0033987718
-
Reversibility of acute B-cell leukaemia induced by BCR-ABL1
-
Huettner CS, Zhang P, Van Etten RA, et al. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat Genet 2000; 24: 57-60.
-
(2000)
Nat Genet
, vol.24
, pp. 57-60
-
-
Huettner, C.S.1
Zhang, P.2
Van Etten, R.A.3
-
34
-
-
0036549015
-
Conditional mouse models of sporadic cancer
-
Jonkers J, Berns A,. Conditional mouse models of sporadic cancer. Nat Rev Cancer 2002; 2: 251-65.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 251-265
-
-
Jonkers, J.1
Berns, A.2
-
35
-
-
0037150729
-
Recent advances in cancer research: Mouse models of tumorigenesis
-
Herzig M, Christofori G,. Recent advances in cancer research: mouse models of tumorigenesis. Biochim Biophys Acta 2002; 1602: 97-113.
-
(2002)
Biochim Biophys Acta
, vol.1602
, pp. 97-113
-
-
Herzig, M.1
Christofori, G.2
-
36
-
-
84886698315
-
Innate and adaptive immune cells in the tumor microenvironment
-
Gajewski TF, Schreiber H, Fu YX,. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 2013; 14: 1014-22.
-
(2013)
Nat Immunol
, vol.14
, pp. 1014-1022
-
-
Gajewski, T.F.1
Schreiber, H.2
Fu, Y.X.3
-
37
-
-
83455173559
-
Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer
-
Anders K, Buschow C, Herrmann A, et al. Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer. Cancer Cell 2011; 20: 755-67.
-
(2011)
Cancer Cell
, vol.20
, pp. 755-767
-
-
Anders, K.1
Buschow, C.2
Herrmann, A.3
-
38
-
-
48549086258
-
Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta
-
Wei S, Shreiner AB, Takeshita N, et al. Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta. Cancer Res 2008; 68: 5432-8.
-
(2008)
Cancer Res
, vol.68
, pp. 5432-5438
-
-
Wei, S.1
Shreiner, A.B.2
Takeshita, N.3
-
39
-
-
0033485422
-
A long-term memory obtained by genetic immunization results in full protection from a mammary adenocarcinoma expressing an EBV gene
-
Charo J, Ciupitu AM, Le Chevalier De Preville A, et al. A long-term memory obtained by genetic immunization results in full protection from a mammary adenocarcinoma expressing an EBV gene. J Immunol 1999; 163: 5913-19.
-
(1999)
J Immunol
, vol.163
, pp. 5913-5919
-
-
Charo, J.1
Ciupitu, A.M.2
Le Chevalier De Preville, A.3
-
40
-
-
0034768115
-
Technical aspects of minimal residual disease detection in carcinoma patients
-
Lacroix J, Doeberitz MK,. Technical aspects of minimal residual disease detection in carcinoma patients. Semin Surg Oncol 2001; 20: 252-64.
-
(2001)
Semin Surg Oncol
, vol.20
, pp. 252-264
-
-
Lacroix, J.1
Doeberitz, M.K.2
-
41
-
-
0036980783
-
Understanding immune cell trafficking patterns via in vivo bioluminescence imaging
-
Mandl S, Schimmelpfennig C, Edinger M, et al. Understanding immune cell trafficking patterns via in vivo bioluminescence imaging. J Cell Biochem Suppl 2002; 39: 239-48.
-
(2002)
J Cell Biochem Suppl
, vol.39
, pp. 239-248
-
-
Mandl, S.1
Schimmelpfennig, C.2
Edinger, M.3
-
42
-
-
49249089425
-
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
-
Fife BT, Bluestone JA,. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev 2008; 224: 166-82.
-
(2008)
Immunol Rev
, vol.224
, pp. 166-182
-
-
Fife, B.T.1
Bluestone, J.A.2
-
43
-
-
25844484607
-
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
-
Gattinoni L, Finkelstein SE, Klebanoff CA, et al. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J Exp Med 2005; 202: 907-12.
-
(2005)
J Exp Med
, vol.202
, pp. 907-912
-
-
Gattinoni, L.1
Finkelstein, S.E.2
Klebanoff, C.A.3
-
44
-
-
69049089548
-
The prioritization of cancer antigens: A national cancer institute pilot project for the acceleration of translational research
-
Cheever MA, Allison JP, Ferris AS, et al. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res 2009; 15: 5323-37.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5323-5337
-
-
Cheever, M.A.1
Allison, J.P.2
Ferris, A.S.3
-
45
-
-
0034078355
-
The liver as a site of T-cell apoptosis: Graveyard, or killing field?
-
Crispe IN, Dao T, Klugewitz K, et al. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev 2000; 174: 47-62.
-
(2000)
Immunol Rev
, vol.174
, pp. 47-62
-
-
Crispe, I.N.1
Dao, T.2
Klugewitz, K.3
-
46
-
-
33746300562
-
In vivo testing of Renilla luciferase substrate analogs in an orthotopic murine model of human glioblastoma
-
Otto-Duessel M, Khankaldyyan V, Gonzalez-Gomez I, et al. In vivo testing of Renilla luciferase substrate analogs in an orthotopic murine model of human glioblastoma. Mol Imaging 2006; 5: 57-64.
-
(2006)
Mol Imaging
, vol.5
, pp. 57-64
-
-
Otto-Duessel, M.1
Khankaldyyan, V.2
Gonzalez-Gomez, I.3
|